1887

Abstract

Viral infection may induce the cell-surface expression of PVR (CD155) that, upon recognition by its cognate activating DNAM-1 receptor present on cytotoxic lymphocytes, may promote antiviral immune responses. Here we show that expression of the human immunodeficiency virus type 1 (HIV-1) Vpr protein in Jurkat T cells increases cell-surface and total PVR levels. Analysis of mutated Vpr variants indicated that Vpr uses the same protein surfaces, and hence probably the same mechanisms, to upregulate PVR and arrest the cell cycle in the G phase. Moreover, we found that PVR upregulation by Vpr relied on the ability of the protein to activate the ATR kinase that triggers the DNA damage response pathway and G arrest. Finally, we showed that Vpr contributes to PVR up-modulation in HIV-infected CD4 T lymphocytes and inhibits the PVR downregulating activity of the viral Nef protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.055541-0
2013-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/12/2664.html?itemId=/content/journal/jgv/10.1099/vir.0.055541-0&mimeType=html&fmt=ahah

References

  1. Andersen J. L., Le Rouzic E., Planelles V. 2008; HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol 85:2–10 [View Article][PubMed]
    [Google Scholar]
  2. Ardolino M., Zingoni A., Cerboni C., Cecere F., Soriani A., Iannitto M. L., Santoni A. 2011; DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK–T cell interaction. Blood 117:4778–4786 [CrossRef]
    [Google Scholar]
  3. Belzile J. P., Duisit G., Rougeau N., Mercier J., Finzi A., Cohen E. A. 2007; HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 3:e85 [View Article][PubMed]
    [Google Scholar]
  4. Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. 2007a; Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 110:606–615 [View Article][PubMed]
    [Google Scholar]
  5. Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., Santoni A., Doria M. 2007b; Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88:242–250 [View Article][PubMed]
    [Google Scholar]
  6. Eissmann P., Evans J. H., Mehrabi M., Rose E. L., Nedvetzki S., Davis D. M. 2010; Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol 184:6901–6909 [View Article][PubMed]
    [Google Scholar]
  7. Gasser S., Orsulic S., Brown E. J., Raulet D. H. 2005; The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186–1190 [View Article][PubMed]
    [Google Scholar]
  8. Goh W. C., Rogel M. E., Kinsey C. M., Michael S. F., Fultz P. N., Nowak M. A., Hahn B. H., Emerman M. 1998; HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4:65–71 [View Article][PubMed]
    [Google Scholar]
  9. Kirchhoff F. 2010; Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55–67 [View Article][PubMed]
    [Google Scholar]
  10. Lau A., Swinbank K. M., Ahmed P. S., Taylor D. L., Jackson S. P., Smith G. C., O’Connor M. J. 2005; Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol 7:493–500 [View Article][PubMed]
    [Google Scholar]
  11. Mansky L. M., Preveral S., Selig L., Benarous R., Benichou S. 2000; The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J Virol 74:7039–7047 [View Article][PubMed]
    [Google Scholar]
  12. Matusali G., Potestà M., Santoni A., Cerboni C., Doria M. 2012; The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 86:4496–4504 [View Article][PubMed]
    [Google Scholar]
  13. Norman J. M., Mashiba M., McNamara L. A., Onafuwa-Nuga A., Chiari-Fort E., Shen W., Collins K. L. 2011; The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 12:975–983 [View Article][PubMed]
    [Google Scholar]
  14. Richard J., Sindhu S., Pham T. N., Belzile J. P., Cohen E. A. 2010; HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115:1354–1363 [View Article][PubMed]
    [Google Scholar]
  15. Soriani A., Zingoni A., Cerboni C., Iannitto M. L., Ricciardi M. R., Di Gialleonardo V., Cippitelli M., Fionda C., Petrucci M. T. other authors 2009; ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113:3503–3511 [View Article][PubMed]
    [Google Scholar]
  16. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., Mandelboim O. 2008; Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9:1065–1073 [View Article][PubMed]
    [Google Scholar]
  17. Takai Y., Miyoshi J., Ikeda W., Ogita H. 2008; Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 9:603–615 [View Article][PubMed]
    [Google Scholar]
  18. Ward J., Davis Z., DeHart J., Zimmerman E., Bosque A., Brunetta E., Mavilio D., Planelles V., Barker E. 2009; HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog 5:e1000613 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.055541-0
Loading
/content/journal/jgv/10.1099/vir.0.055541-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error